InvestorsHub Logo
Followers 0
Posts 177
Boards Moderated 0
Alias Born 08/04/2009

Re: koolmc post# 844

Monday, 11/02/2009 10:38:05 PM

Monday, November 02, 2009 10:38:05 PM

Post# of 3283
Lol, yea, it's so lively there haa.

Oh well. SPPI board is quiet. I think when news hits that CMS has agreed to reimburse SPPI, there will be a shockwave upwards to the $6.

This drug is a no brainer.

SPPI approved for 1st line consolidation.

10% of the patient pool is already 4400.

At $20000 per drug, assume lowest reimubrsement, this is already $88mln revenue. SPPI can see profits of $20mln a year.

That's EPS of $0.45

This will be the best EOQUIN play, CTIC and all are facing depleting cash, while SPPI has a blockbuster drug plus net cashflow.. which makes this stock very expensive.

I will not be surprise to see EPS X 30 for this type of stock.

Especially with EOQUIN potential in 2011. A real no brainer.

I check EOQUIN potential, it is about 1bln worldwide.
EOQUIN is the RITUXAN for bladder cancer.


SPPI getting 20% royalties, so 200mln profits a year. Nice deal. (HGSI royalties are higher... at 30%)

That's $4 EPS. I cant think of it anymore lol. $40 PPS in 2011... wow, 10X gains. I hope so.